Indications and uses
temporarily protects and helps relieve chapped or cracked skin temporarily protects minor cuts scrapes burns
temporarily protects and helps relieve chapped or cracked skin temporarily protects minor cuts scrapes burns
Apply cream liberally as often as needed
Drug Facts
Dimethicone 1%
Skin protectant
For external use only
Apply cream liberally as often as needed
Water, Mineral Oil, White Petrolatum, Ceresin, Sorbitan Sesquioleate, Sorbitol, Lanolin Alcohol, Aluminum Hydroxide, Magnesium Hydroxide, BHT Ethylhexylglycerin, Phenoxyethanol
9a-5p weekdays M-F CST 1-877-725-7274
Distributed by
GinJen
Hammond, LA 70401
PATENTED
Smooth,
Soothing,
Cooling Cream
for Skin
Affected
by Incontinence
and Inactivity
NEW
DEVELOPED BY A PHYSICIAN
NeutrapHor
®
SKIN PROTECTANT CREAM
Long Term Relief
pH-Mediated
CLINIC
FRAGRANCE FREE
Distributed by
GinJen
Hammond, LA 70401
1-877-725-7274
Patent 6805875
Patents Pending
2.0 oz (57 g)
www.neutraphor.com

| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 200010 | dimethicone 1 % Topical Cream | PSN | 2 |
| 1044932 | NeutrapHor 1 % Topical Cream | PSN | 2 |
| 1044932 | dimethicone 10 MG/ML Topical Cream [NeutrapHor] | SBD | 2 |
| 200010 | dimethicone 10 MG/ML Topical Cream | SCD | 2 |
| 200010 | dimethicone 1 % Topical Cream | SY | 2 |
| 1044932 | NeutrapHor 1 % Topical Cream | SY | 2 |
| 1044932 | NeutrapHor 10 MG/ML Topical Cream | SY | 2 |
| Class | Version | Type | Effective |
|---|---|---|---|
| DIMETHICONE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6084a4f4-5437-c9a5-caec-5361ee075a59 | Product name | 1 | 20140508 |
| 90c5639a-61b0-88d6-ddcf-21888e94869a | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50952-002-01 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c31a-8e05-e053-dbdaa90a074a | NeutrapHor ® SKIN PROTECTANT CREAM |
| 50952-002-02 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c31a-8e05-e053-dbdaa90a074a | NeutrapHor ® SKIN PROTECTANT CREAM |
| 50952-002-03 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c31a-8e05-e053-dbdaa90a074a | NeutrapHor ® SKIN PROTECTANT CREAM |
| 50952-002-04 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c31a-8e05-e053-dbdaa90a074a | NeutrapHor ® SKIN PROTECTANT CREAM |
| 50952-002-05 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c31a-8e05-e053-dbdaa90a074a | NeutrapHor ® SKIN PROTECTANT CREAM |
| 50952-002-06 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c31a-8e05-e053-dbdaa90a074a | NeutrapHor ® SKIN PROTECTANT CREAM |
| 50952-002-07 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c31a-8e05-e053-dbdaa90a074a | NeutrapHor ® SKIN PROTECTANT CREAM |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50952-002-01 | NeutrapHor Skin Protectant | 57 g in 1 JAR | CREAM | 57 | 2 | |
| 50952-002-02 | NeutrapHor Skin Protectant | 57 g in 1 JAR | CREAM | 57 | 2 | |
| 50952-002-02 | NeutrapHor Skin Protectant | 4 in 1 BOX | CREAM | 4 | 2 | |
| 50952-002-03 | NeutrapHor Skin Protectant | 12 in 1 BOX | CREAM | 12 | 2 | |
| 50952-002-03 | NeutrapHor Skin Protectant | 57 g in 1 JAR | CREAM | 57 | 2 | |
| 50952-002-04 | NeutrapHor Skin Protectant | 10 in 1 BOX | CREAM | 10 | 2 | |
| 50952-002-04 | NeutrapHor Skin Protectant | 10 g in 1 PACKET | CREAM | 10 | 2 | |
| 50952-002-05 | NeutrapHor Skin Protectant | 10 g in 1 PACKET | CREAM | 10 | 2 | |
| 50952-002-05 | NeutrapHor Skin Protectant | 25 in 1 BOX | CREAM | 25 | 2 | |
| 50952-002-06 | NeutrapHor Skin Protectant | 100 in 1 BOX | CREAM | 100 | 2 | |
| 50952-002-06 | NeutrapHor Skin Protectant | 10 g in 1 PACKET | CREAM | 10 | 2 | |
| 50952-002-07 | NeutrapHor Skin Protectant | 144 in 1 BOX | CREAM | 144 | 2 | |
| 50952-002-07 | NeutrapHor Skin Protectant | 10 g in 1 PACKET | CREAM | 10 | 2 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50952-002-01 | GM - Gram | 50952-002 | 3c3c2726-d44c-492f-82fb-7a8eeac410a7 | 1 | 2012-07-24 |
| 50952-002-02 | GM - Gram | 50952-002 | f02a7f97-7059-4287-87dc-f6e7a4a52e0e | 1 | 2012-07-24 |
| 50952-002-03 | GM - Gram | 50952-002 | 0802f99f-849c-4fc8-ac41-134471201180 | 1 | 2012-07-24 |
| 50952-002-04 | GM - Gram | 50952-002 | d95ebcdb-c37e-4259-a394-0d57c070b8ad | 1 | 2012-07-24 |
| 50952-002-05 | GM - Gram | 50952-002 | 51b6e390-3c0f-4976-884d-7d1814c2d0e0 | 1 | 2012-07-24 |
| 50952-002-06 | GM - Gram | 50952-002 | c5bd37b7-bf92-4249-b5e0-370617ac4f69 | 1 | 2012-07-24 |
| 50952-002-07 | GM - Gram | 50952-002 | ac677add-098e-49ba-b0a4-c595c52094fc | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Dimethicone | ACTIVE INGREDIENT | 92RU3N3Y1O | 2 | |
| Dimethicone | ACTIVE MOIETY | 92RU3N3Y1O | 2 | |
| Aluminum Hydroxide | INACTIVE INGREDIENT | 5QB0T2IUN0 | 2 | |
| Butylated Hydroxytoluene | INACTIVE INGREDIENT | 1P9D0Z171K | 2 | |
| Ethylhexylglycerin | INACTIVE INGREDIENT | 147D247K3P | 2 | |
| Lanolin Alcohols | INACTIVE INGREDIENT | 884C3FA9HE | 2 | |
| Magnesium Hydroxide | INACTIVE INGREDIENT | NBZ3QY004S | 2 | |
| Mineral Oil | INACTIVE INGREDIENT | T5L8T28FGP | 2 | |
| Petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 2 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 2 | |
| Sorbitan Sesquioleate | INACTIVE INGREDIENT | 0W8RRI5W5A | 2 | |
| Sorbitol | INACTIVE INGREDIENT | 506T60A25R | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50952-002 | 50952-002-01, 50952-002-02, 50952-002-03, 50952-002-04, 50952-002-05, 50952-002-06, 50952-002-07 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Dimethicone | 92RU3N3Y1O | ACTIB |
| Water | 059QF0KO0R | IACT |
| Mineral Oil | T5L8T28FGP | IACT |
| Petrolatum | 4T6H12BN9U | IACT |
| Sorbitan Sesquioleate | 0W8RRI5W5A | IACT |
| Sorbitol | 506T60A25R | IACT |
| Lanolin Alcohols | 884C3FA9HE | IACT |
| Aluminum Hydroxide | 5QB0T2IUN0 | IACT |
| Magnesium Hydroxide | NBZ3QY004S | IACT |
| Butylated Hydroxytoluene | 1P9D0Z171K | IACT |
| Ethylhexylglycerin | 147D247K3P | IACT |
| Phenoxyethanol | HIE492ZZ3T | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sorbitol | SORBITOL | 506T60A25R | TABLET, CHEWABLE / ORAL | 3555 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | CREAM, AUGMENTED / TOPICAL | 15 %w/w | ||
| Sorbitol | SORBITOL | 506T60A25R | GUM, CHEWING / ORAL | 6168 mg | ||
| Magnesium Hydroxide | MAGNESIUM HYDROXIDE | NBZ3QY004S | TABLET / ORAL | 120 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SYSTEM / TOPICAL | 654.36 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | OINTMENT / TOPICAL | 57 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w | ||
| Sorbitol | SORBITOL | 506T60A25R | INJECTION / INTRAVENOUS | 1276 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | INJECTION, SOLUTION / INTRAVENOUS | NA | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE / VAGINAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| Sorbitol | SORBITOL | 506T60A25R | CONCENTRATE / ORAL | 600 mg/1ml | ||
| Sorbitan Sesquioleate | SORBITAN SESQUIOLEATE | 0W8RRI5W5A | OINTMENT / TOPICAL | 75 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | SYRUP / ORAL | 4370 mg/5ml | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | GEL / TOPICAL | 8 mg | ||
| Lanolin Alcohols | LANOLIN ALCOHOLS | 884C3FA9HE | OINTMENT / TOPICAL | 452 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SPRAY / TOPICAL | 1379 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| Lanolin Alcohols | LANOLIN ALCOHOLS | 884C3FA9HE | LOTION / TOPICAL | 9360 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | GEL, METERED / TOPICAL | 4 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CAPSULE / ORAL | 120 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | TABLET, FOR SUSPENSION / ORAL | 0.1 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SUPPOSITORY / VAGINAL | NA | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SOLUTION, CONCENTRATE / ORAL | 0.1 mg/1ml | ||
| Sorbitan Sesquioleate | SORBITAN SESQUIOLEATE | 0W8RRI5W5A | OINTMENT / RECTAL | 15 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SOAP / TOPICAL | 0.02 %w/w | ||
| Sorbitol | SORBITOL | 506T60A25R | SOLUTION / ORAL | 29268 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / OPHTHALMIC | 0.1 %w/w | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CAPSULE, EXTENDED RELEASE / ORAL | 0.03 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | SOLUTION / OPHTHALMIC | 6 mg | ||
| Magnesium Hydroxide | MAGNESIUM HYDROXIDE | NBZ3QY004S | TABLET, FILM COATED / ORAL | 43.4 mg | ||
| Aluminum Hydroxide | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | TABLET / ORAL | 50 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SWAB / TOPICAL | 0.5 %w/w | ||
| Sorbitol | SORBITOL | 506T60A25R | SOLUTION / NASAL | 25 mg/1ml | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET, EXTENDED RELEASE / ORAL | 428 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | GEL / TOPICAL | 2.5 %w/w | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | NA | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET / ORAL | 337.28 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | SUSPENSION / ORAL | 45000 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CAPSULE / ORAL | 3 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CREAM / VAGINAL | 0.05 %w/w | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 0.02 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | INJECTION / INTRAVENOUS | NA | ||
| Sorbitol | SORBITOL | 506T60A25R | LOTION / TOPICAL | 10.7 %w/w | ||
| Magnesium Hydroxide | MAGNESIUM HYDROXIDE | NBZ3QY004S | CAPSULE, DELAYED RELEASE / ORAL | 6.7 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | AEROSOL, FOAM / TOPICAL | 4 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | INJECTION / INTRAMUSCULAR | NA | ||
| Sorbitol | SORBITOL | 506T60A25R | LIQUID / TOPICAL | 1 %w/w | ||
| Sorbitol | SORBITOL | 506T60A25R | POWDER / ORAL | 36000 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | TABLET / SUBLINGUAL | 0.13 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | POWDER, FOR SUSPENSION / ORAL | 12000 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | SOLUTION/ DROPS / OPHTHALMIC | 0.25 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 84104452-0a4d-47f2-a65d-c9c3fd85f9a8 | 0f3a5ca3-c4bd-4496-bb62-816d1ed9f01f | 2010-11-19 | Warnings | 84104452-0a4d-47f2-a65d-c9c3fd85f9a8 0f3a5ca3-c4bd-4496-bb62-816d1ed9f01f |
Adverse event summaries are temporarily unavailable. Other product information remains available.